RELATIVE WALL THICKNESS AND
THE RISK FOR VENTRICULAR
TACHYARRHYTHMIAS IN PATIENTS
WITH LV DYSFUNCTION
 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y;2016
INTRODUCTION
 Reduced LVEF and the presence of myocardial
scar are associated with higher risk of ventricular
arrhythmia (VA) and SCD
 ICD-reduces mortality associated with VA
 CRT-D compared with ICD -reduces VA incidence by
reverse remodelling
 We assessed relationship between remodelling and
the risk for VA
Assessment of Remodeling
patterns of the LV by echo
 relative wall thickness (RWT)

 concentric remodeling(high RWT) is associated
with increased morbidity and mortality in
hypertensive patients with HCM-Hiwada K et al
 Relation between the magnitude of eccentric
hypertrophy(low RWT) and the risk of VA in DCM –
scarce data
MADIT –CRT TRIAL (Multicenter Automatic Defibrillator
Implantation Trial With Cardiac Resynchronization
Therapy)
 patients who had ischemic cardiomyopathy (NYHA FC I or II)
or nonischemic cardiomyopathy (NYHA FC II), LVEF ≤30%,
normal sinus rhythm, and QRS duration ≥130 ms, were
randomized to receive CRT-D or ICD therapy in a 3:2 ratio.
 superiority of CRT -41% reduction in the risk of heart-failure
events, more so in patients with a QRS duration of 150 msec or
more.
 CRT -significant reduction in LV volumes and improvement in
EF
 no significant difference between the two groups in the
overall risk of death, with a 3% annual mortality rate in each
treatment group
AIMS
 1) the predictive value of RWT for the risk of VA
compared with other commonly used echo variables
 2) the relationship between LV morphology and the
risk of VA by measuring RWT; and
 3) the remodelling effect of CRT-D on RWT.
METHODS
 1,260 patients enrolled in the MADIT-CRT trial with
LBBB at baseline electrocardiogram .
 programmed to monitor and deliver therapy, ATP,
and/or shock therapy
 interrogated 1 month after enrolment ;thereafter
every 3 months
 VA episode was defined when device-rendered
therapy ( ATP or shock) was appropriately delivered.
 VT= episode with ventricular rates between 180 and
250 beats/min
 VF- episode with ventricular rates ≥250 beats/min.
 Fast VT = episode with ventricular rates ≥200
beats/min or VF.
 Echo - baseline, which was before device implantation,
and at 1 year
 Septal wall thickness (SWT) and posterior wall thickness
(PWT) were assessed in PLAX view
 RWT = 2 times PWT divided by the LV diastolic diameter
 second method =sum of SWT and PWT divided by LV
diastolic diameter
 Patients were dichotomized between the lowest RWT
tertile (<0.24) and the upper 2 tertiles (≥0.24)
 primary endpoint - combined endpoint of VT or VF.
 Secondary endpoints -separate endpoints of VT, VF, fast
VT , and the combined endpoint of VT,VF, and death.
RESULTS
RELATIONSHIP BETWEEN RWT AND
VA.
 compared the risk associated with several echo
parameters (including LVEDV, LVESV, LA volume,
LVEF, LV mass, and LV mass/LVEDV ratio)
 RWT –best echocardiographic variable
 Patients with low RWT (<0.24) had 83% (p < 0.001)
increased risk for VA and 68% (p < 0.001) increase in
VA risk or death (VA/death) compared with patients
with higher RWT values.
 RWT was a significant and superior predictor even
when combined with other echo variables and added
significantly to the predictive capacity of all of the
models .
 The 2 components of RWT, LVEDD and LV PWT,
were significant independent predictors of VT/VF
and VT/VF/death.
 LVEDD was a better predictor versus LVPWT
 wider LVEDD -increased hazard; lower LVPWT -
harmful
 RWT had a better fit compared with its 2 components
and with the LV mass/LVEDV ratio
Patients with low RWT had a significantly higher VA and VA/death
events
multivariable analysis
 lower RWT as either categorical or continuous (i.e., every
0.01-U decrease in RWT) variable was significantly related
to higher event rates
 significant, even after further adjustments to baseline
differences (BNP, BMI, and smoking),and in all pre-
specified subgroups
 consistent when an alternative formula was used for
measuring RWT (SWT +PWT divided by LVEDD)
 each 0.01-U decrease in RWT
1. 11% (HR: 0.89;p < 0.001) increase in the risk of VA
2. 9% (HR: 0.91;p < 0.001) increase in the risk of VA
/death
THE EFFECT OF CRT-D ON RWT
 greater increase in RWT compared with ICD therapy
at 12 months (4.6 +/- 6.8% vs. 1.5 +/-2.7%; p < 0.001).
 Kaplan-Meier survival analysis -cumulative probability
of a first occurrence of VT/VF 3 years after assessment
of echo response was significantly lower in those with
increased RWT compared with those with lower
changes in RWT at 12 months.
 every 10% increase of RWT at 12months -34% and
36% reductions in the rates of subsequent VA events
and subsequent VA/death
 Baseline RWT was a significant predictor of VT/VF in
both the ischemic and nonischemic subgroups
 HR for the ischemic subgroup was 1.11 and for the
nonischemic subgroup was 1.12
 RWT increase at 12 months was associated with risk
reduction for VT/VF in both subgroups
DISCUSSION
 RWT was the best echo predictor for VA events
compared with commonly used echo measurements
 RWT was inversely related to the risk of VA in
patients with eccentric hypertrophy
 increased RWT after 1 year of CRT-D treatment was
related to lower risk for VA in patients with eccentric
hypertrophy
 In the present study, almost all of the patients had
eccentric hypertrophy (RWT <0.32), and only a few
had normal geometry (0.32 < RWT <0.42), as one
would expect in the case of severe systolic HF leading
to dilated cardiomyopathy
mechanisms
 remodeling process of the diseased heart is characterized
by the replacement of necrotized myocytes with
fibroblasts, which in turn increase collagen formation
 This process induces fibrosis and scar formation that can
potentially cause even healthy myocytes to undergo
apoptosis; this paradigm is known to serve as a substrate
for reentry circuits, EADs, and the formation of VA,
especially in patients with enlarged ventricles with slowed
impulse propagation velocities over fibrotic tissue
 Fibrosis enhances the ability of oxidative stress to induce
spontaneous VF
 eccentric hypertrophy, the magnitude of RWT can
mirror the extent of LV fibrosis and scarring on one
hand and the extent of the remodeling process on
the other hand
 both of these measures (wall thickness as a measure
of wall fibrosis and diastolic diameter as a
measure of remodeling) were independently
associated with the risk of VA.
 RWT had a higher predictive capacity compared with
its own components.
STUDY LIMITATIONS
 Retrospective, nonrandomized post-hoc study
 Even after adjustment for many confounders, this was
not a prospective trial and so possible unmeasured
confounders may have biased the results
 Only included patients with LBBB morphology
because CRT-D benefit was shown to be limited to this
subgroup
CONCLUSIONS
 Defining the baseline degree of eccentric hypertrophy
using RWT measurement can be useful for prediction
of VA in patients with impaired LVEF and mild HF
 among patients implanted with a CRTD device, the
magnitude of RWT increase attributed to CRT-D can
predict VA risk as well
THANK YOU
relative wall thickness
relative wall thickness
relative wall thickness
relative wall thickness
relative wall thickness
relative wall thickness

relative wall thickness

  • 1.
    RELATIVE WALL THICKNESSAND THE RISK FOR VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH LV DYSFUNCTION  J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y;2016
  • 2.
    INTRODUCTION  Reduced LVEFand the presence of myocardial scar are associated with higher risk of ventricular arrhythmia (VA) and SCD  ICD-reduces mortality associated with VA  CRT-D compared with ICD -reduces VA incidence by reverse remodelling  We assessed relationship between remodelling and the risk for VA
  • 3.
    Assessment of Remodeling patternsof the LV by echo  relative wall thickness (RWT) 
  • 7.
     concentric remodeling(highRWT) is associated with increased morbidity and mortality in hypertensive patients with HCM-Hiwada K et al  Relation between the magnitude of eccentric hypertrophy(low RWT) and the risk of VA in DCM – scarce data
  • 8.
    MADIT –CRT TRIAL(Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)  patients who had ischemic cardiomyopathy (NYHA FC I or II) or nonischemic cardiomyopathy (NYHA FC II), LVEF ≤30%, normal sinus rhythm, and QRS duration ≥130 ms, were randomized to receive CRT-D or ICD therapy in a 3:2 ratio.  superiority of CRT -41% reduction in the risk of heart-failure events, more so in patients with a QRS duration of 150 msec or more.  CRT -significant reduction in LV volumes and improvement in EF  no significant difference between the two groups in the overall risk of death, with a 3% annual mortality rate in each treatment group
  • 9.
    AIMS  1) thepredictive value of RWT for the risk of VA compared with other commonly used echo variables  2) the relationship between LV morphology and the risk of VA by measuring RWT; and  3) the remodelling effect of CRT-D on RWT.
  • 10.
    METHODS  1,260 patientsenrolled in the MADIT-CRT trial with LBBB at baseline electrocardiogram .  programmed to monitor and deliver therapy, ATP, and/or shock therapy  interrogated 1 month after enrolment ;thereafter every 3 months  VA episode was defined when device-rendered therapy ( ATP or shock) was appropriately delivered.
  • 12.
     VT= episodewith ventricular rates between 180 and 250 beats/min  VF- episode with ventricular rates ≥250 beats/min.  Fast VT = episode with ventricular rates ≥200 beats/min or VF.
  • 13.
     Echo -baseline, which was before device implantation, and at 1 year  Septal wall thickness (SWT) and posterior wall thickness (PWT) were assessed in PLAX view  RWT = 2 times PWT divided by the LV diastolic diameter  second method =sum of SWT and PWT divided by LV diastolic diameter  Patients were dichotomized between the lowest RWT tertile (<0.24) and the upper 2 tertiles (≥0.24)  primary endpoint - combined endpoint of VT or VF.  Secondary endpoints -separate endpoints of VT, VF, fast VT , and the combined endpoint of VT,VF, and death.
  • 14.
  • 15.
    RELATIONSHIP BETWEEN RWTAND VA.  compared the risk associated with several echo parameters (including LVEDV, LVESV, LA volume, LVEF, LV mass, and LV mass/LVEDV ratio)  RWT –best echocardiographic variable  Patients with low RWT (<0.24) had 83% (p < 0.001) increased risk for VA and 68% (p < 0.001) increase in VA risk or death (VA/death) compared with patients with higher RWT values.
  • 17.
     RWT wasa significant and superior predictor even when combined with other echo variables and added significantly to the predictive capacity of all of the models .
  • 18.
     The 2components of RWT, LVEDD and LV PWT, were significant independent predictors of VT/VF and VT/VF/death.  LVEDD was a better predictor versus LVPWT  wider LVEDD -increased hazard; lower LVPWT - harmful  RWT had a better fit compared with its 2 components and with the LV mass/LVEDV ratio
  • 19.
    Patients with lowRWT had a significantly higher VA and VA/death events
  • 21.
    multivariable analysis  lowerRWT as either categorical or continuous (i.e., every 0.01-U decrease in RWT) variable was significantly related to higher event rates  significant, even after further adjustments to baseline differences (BNP, BMI, and smoking),and in all pre- specified subgroups  consistent when an alternative formula was used for measuring RWT (SWT +PWT divided by LVEDD)  each 0.01-U decrease in RWT 1. 11% (HR: 0.89;p < 0.001) increase in the risk of VA 2. 9% (HR: 0.91;p < 0.001) increase in the risk of VA /death
  • 23.
    THE EFFECT OFCRT-D ON RWT  greater increase in RWT compared with ICD therapy at 12 months (4.6 +/- 6.8% vs. 1.5 +/-2.7%; p < 0.001).  Kaplan-Meier survival analysis -cumulative probability of a first occurrence of VT/VF 3 years after assessment of echo response was significantly lower in those with increased RWT compared with those with lower changes in RWT at 12 months.  every 10% increase of RWT at 12months -34% and 36% reductions in the rates of subsequent VA events and subsequent VA/death
  • 25.
     Baseline RWTwas a significant predictor of VT/VF in both the ischemic and nonischemic subgroups  HR for the ischemic subgroup was 1.11 and for the nonischemic subgroup was 1.12  RWT increase at 12 months was associated with risk reduction for VT/VF in both subgroups
  • 26.
    DISCUSSION  RWT wasthe best echo predictor for VA events compared with commonly used echo measurements  RWT was inversely related to the risk of VA in patients with eccentric hypertrophy  increased RWT after 1 year of CRT-D treatment was related to lower risk for VA in patients with eccentric hypertrophy
  • 27.
     In thepresent study, almost all of the patients had eccentric hypertrophy (RWT <0.32), and only a few had normal geometry (0.32 < RWT <0.42), as one would expect in the case of severe systolic HF leading to dilated cardiomyopathy
  • 28.
    mechanisms  remodeling processof the diseased heart is characterized by the replacement of necrotized myocytes with fibroblasts, which in turn increase collagen formation  This process induces fibrosis and scar formation that can potentially cause even healthy myocytes to undergo apoptosis; this paradigm is known to serve as a substrate for reentry circuits, EADs, and the formation of VA, especially in patients with enlarged ventricles with slowed impulse propagation velocities over fibrotic tissue  Fibrosis enhances the ability of oxidative stress to induce spontaneous VF
  • 30.
     eccentric hypertrophy,the magnitude of RWT can mirror the extent of LV fibrosis and scarring on one hand and the extent of the remodeling process on the other hand  both of these measures (wall thickness as a measure of wall fibrosis and diastolic diameter as a measure of remodeling) were independently associated with the risk of VA.  RWT had a higher predictive capacity compared with its own components.
  • 31.
    STUDY LIMITATIONS  Retrospective,nonrandomized post-hoc study  Even after adjustment for many confounders, this was not a prospective trial and so possible unmeasured confounders may have biased the results  Only included patients with LBBB morphology because CRT-D benefit was shown to be limited to this subgroup
  • 32.
    CONCLUSIONS  Defining thebaseline degree of eccentric hypertrophy using RWT measurement can be useful for prediction of VA in patients with impaired LVEF and mild HF  among patients implanted with a CRTD device, the magnitude of RWT increase attributed to CRT-D can predict VA risk as well
  • 33.